Ledipasvir + Sofosbuvir

Category: Hepatitis



Ledipasvir + Sofosbuvir Overview

Ledipasvir is a drug for the treatment of hepatitis C that was developed by Gilead Sciences.[1] After completing Phase III clinical trials, on February 10, 2014 Gilead filed for U.S. approval of a ledipasvir/sofosbuvir fixed-dose combination tablet for genotype 1 hepatitis C.[2][3] The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or...

Read more Ledipasvir + Sofosbuvir Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ledipasvir

Recent Ledipasvir + Sofosbuvir Forums: RSS Feed

Which is the efficiency of the Ledipasvir + Sofosbuvir?

Please, be so kind and tell me if you have some reference about "LEDVIR", do you think that this medicine could be administrated with god results in F2 stage of Hepatite C, genotype 1b? Ledipasvir + Sofosbuvir will destroy for ever the C virus? or the C virus will be eliminated just for a period of tme?

Updated
POST A REPLYSHARE 

Possible Dosages for this and Related Drugs:

Ledipasvir + Sofosbuvir
  • Pellets: 33.75mg + 150mg/packet, 45mg + 200mg/packet
  • Tablet: 45mg + 200mg, 90mg + 400mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ledipasvir + Sofosbuvir: (2 results)

Sorted by National Drug Code
  • 61958-1802 Ledipasvir 90 mg / Sofosbuvir 400 mg Oral Tablet [Harvoni] by Gilead Sciences, Inc
  • 72626-2601 Ledipasvir and Sofosbuvir Oral Tablet, Film Coated by Asegua Therapeutics LLC

Drugs with one or more similar ingredients: (7 results)

Related Ledipasvir + Sofosbuvir Topics:

Which is the efficiency of the Ledipasvir + Sofosbuvir?
Please, be so kind and tell me if you have some reference about "LEDVIR", do you think that this medicine could ...